Foreword: the inheritance of loss by Fisher, N

Analytics for leaders : a performance measurement system for business success / by Fisher, N. I author

Measuring angiogenic cytokines, circulating endothelial cells, and endothelial progenitor cells in peripheral blood and cord blood: VEGF and CXCL12 correlate with the number of cir... by Smythe, J, Fox, A, Fisher, N, Frith, E, Harris, A, Watt, S

The Elton Archive by Pond, C, Elton, C, Clarke, J, Fisher, N, Mann, D, Kirby, K

Other Authors: “…Fisher, N…”

Mobilization of endothelial progenitor cells into the circulation in burned patients. by Fox, A, Smythe, J, Fisher, N, Tyler, M, McGrouther, D, Watt, S, Harris, A

Quantification of circulating cell-free plasma DNA and endothelial gene RNA in patients with burns and relation to acute thermal injury. by Fox, A, Gal, S, Fisher, N, Smythe, J, Wainscoat, J, Tyler, M, Watt, S, Harris, A

The impact of proliferative potential of umbilical cord-derived endothelial progenitor cells and hypoxia on vascular tubule formation in vitro. by Zhang, Y, Fisher, N, Newey, S, Smythe, J, Tatton, L, Tsaknakis, G, Forde, S, Carpenter, L, Athanassopoulos, T, Hale, S, Ferguson, D, Tyler, M, Watt, S

Circulating tumor DNA predicts survival in patients with resected high risk stage II/III melanoma. by Lee, R, Gremel, G, Marshall, A, Myers, K, Fisher, N, Dunn, J, Dhomen, N, Corrie, P, Middleton, M, Lorigan, P, Marais, R

Phase I study of copper-binding agent ATN-224 in patients with advanced solid tumors. by Lowndes, SA, Adams, A, Timms, A, Fisher, N, Smythe, J, Watt, S, Joel, S, Donate, F, Hayward, C, Reich, S, Middleton, M, Mazar, A, Harris, A

A phase I study of the safety, tolerability and antitumor activity of escalating doses of combretastatin A4 phosphate (CA4P) given in combination with bevacizumab to subjects with... by Nathan, P, Judson, I, Padhani, A, Harris, A, Sinha, R, Jane, B, Smythe, J, Fisher, N, Taylor, J, Collins, D, Connors, H, Gordon, R

Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer. by Nathan, P, Zweifel, M, Padhani, A, Koh, D, Ng, M, Collins, D, Harris, A, Carden, C, Smythe, J, Fisher, N, Taylor, N, Stirling, J, Lu, S, Leach, M, Rustin, G, Judson, I

Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria. by Biagini, G, Fisher, N, Shone, A, Mubaraki, M, Srivastava, A, Hill, A, Antoine, T, Warman, A, Davies, J, Pidathala, C, Amewu, R, Leung, S, Sharma, R, Gibbons, P, Hong, D, Pacorel, B, Lawrenson, A, Charoensutthivarakul, S, Taylor, L, Berger, O, Mbekeani, A, Stocks, P, Nixon, G, Chadwick, J, Hemingway, J

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours by Horsley, L, Cummings, J, Middleton, M, Ward, T, Backen, A, Clamp, A, Dawson, M, Farmer, H, Fisher, N, Halbert, G, Halford, S, Harris, A, Hasan, J, Hogg, P, Kumaran, G, Little, R, Parker, G, Potter, P, Saunders, M, Roberts, C, Shaw, D, Smith, N, Smythe, J, Taylor, A, Turner, H

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours. by Horsley, L, Cummings, J, Middleton, M, Ward, T, Backen, A, Clamp, A, Dawson, M, Farmer, H, Fisher, N, Halbert, G, Halford, S, Harris, A, Hasan, J, Hogg, P, Kumaran, G, Little, R, Parker, G, Potter, P, Saunders, M, Roberts, C, Shaw, D, Smith, N, Smythe, J, Taylor, A, Turner, H